TPG, Carlyle still mulling Healthscope strategy
- {{x.value}}
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
We have sent you an email with the details of your registration.
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
- Verify your email address by clicking on the link we sent to {{user.Email}}
- You now have free access, we look forward to helping you on your financial journey.
By Brett Cole
Private equity leviathans Carlyle Group and TPG Capital have yet to decide on whether to sell Healthscope to another company, pursue an initial public offering or simply continue to own the hospital operator a little longer, according to people familiar with the matter.
Meetings are continuing at TPG and Carlyle about what to do with Healthscope, which the two US firms paid $2 billion for in 2010 using a mixture of cash and debt.
The firms have invited eight investment banks to make presentations on their recommendations for the health group.
Official appointments on roles for any of the eight investment banks have yet to be made.
The banks that have presented proposals are Bank of America Merrill Lynch, CIMB, Credit Suisse, Goldman Sachs, Deutsche Bank, Macquarie Group, Morgan Stanley and UBS.
Healthscope was formed in 1985 and is now Australia’s largest provider of integrated healthcare, according to its website.
It has 4,500 inpatient beds across 33 hospitals, four mental health hospitals, four rehabilitation facilities, a pathology business, 60 medical centres and specialist skin clinics as well as a veterinary pathology unit.
Call 1300 880 160
Start a chat
Schedule a call
